- +49 201 43 70 97 0
- info@pakumed.de
- Mon - Fri: 8:30 - 17:00
© 2022 All rights reserved
Made by Uvision
Yes ANOKRYO® can be used during these periods without any problems. As opposed to other gel and ointment preparations, there are no side effects.
Depending on symptoms approx. 3-4 x daily.
This is not a problem. The important thing is that the ANOKRYO® rod be stored in the freezer. Normal refrigerator temperatures are insufficient.
No! Due to its water solubility it would freeze. The gel is applied prior to use.
No there are no adverse effects (see IFU).
Yes without any problems. Anokryo is also helpful in treating constipation
ANOKRYO® is available in the pharmacy or may be ordered there on a non-prescription basis. You may order it at this internet site.
You can purchase the product at this internet website. Modes of payment are explained at the site.
ANOKRYO® -combi-set: PZN 03941536.
ANOKRYO® -gel: PZN 07470157.
Since 1990
Yes the instructions for usage have been translated in various languages.
No. There is only one production size.
The rod is made of tissue compatible plastic.
Puncture of the port system requires using a special needle with a beveled tip. Only with these needles can punch defects of the silicone membrane be avoided. Needles are available in different lengths and bore diameters depending on which substances are to be injected, patient anatomy and place and manner of use.
The port needle is used to puncture the port chamber. Thereby, the needle tip goes through a silicone membrane of the port.
Only port needles have a special needle tip. Only with these needles can punch defects of the silicone membrane be avoided.
it is dual safe as it has a special safety system which helps to avoid a needle stick injury.
The operator finds all details on the safety system in the respective IFU.
All FDA drugs intended for intravenous application can be administered via the port/catheter system. These include infusions such as saline, glucose, electrolytes, anti-neoplastic agents, and analgesics such as morphine. As well as parenteral nutrition e.g. fats, amino acids, and blood products (thrombocyte concentrates).
The choice of size depends on, among other things, the patient’s anatomy, the place and type of application. It is the decision of the doctors.
The port cannula is for single use and can remain in the port for up to 48 hours (recommendation). This means that it can be used to administer medicines and fluids, such as artificial food, over a longer period of time.
SFN stands for “Stanzfreie Nadel” which means “non coring needle”
A “huber needle” (named after the inventor) is a often used port needle to access the port.
The tip differs from the SFN port needle made by PakuMed.
Yes, we however highly recommend our 100% guaranteed non coring SFN port needles.
Patients may either be in the sitting or supine position. Sterile technique is mandatory when puncture is performed to prevent infection thus ensuring long-term usage. Patients should turn their heads in the opposite direction of the puncture site and avoid speaking and breathing over the sterile field.
Sample procedure:
IMPORTANT: A needle is strictly intended for single use only and should not remain in place for more than 48h (danger of infection).
This portcathetersystem in combination with special portneedles is also indicated for power injection ( high pressure) of radiopaque material into the vascular blood system.
The system is appropriate to a maximum flow of 5ml/sec at maximum pressure of 300 PSI/21bar. Stability is tested and the suitable systems or needles are indicated separately.
A port catheter system , abbreviated as port, port catheter, or port system, provides long-term access to the vascular system. The system is implanted below the protecting skin barrier. The implantation is a relatively simple procedure which can be performed on an out-patient basis under local anesthesia.
The port/catheter system consists of a titanium port chamber and a catheter. The titanium chamber is sealed by a silicone membrane. Administration of medications, parenteral nutrition, and blood sampling are possible after inserting a special needle through the skin and the silicone membrane into the port chamber.
The port catheter system ensures long-term access to the vascular system in which the catheter is usually placed into a vein. This allows access to the circulation at any time and prevents irritation of the veins that is generally caused by repeated venous injections.
The risk of infection is minimized by the protective skin barrier.
The system is most often used in cancer patients requiring extensive chemotherapy.
Quality of life is optimized because the system does not interfere with patient mobility and puncture of the port membrane is easier and is associated with fewer risks.
Normal activities such as sports, bicycling, etc. are possible.
The implanted port chamber lies slightly elevated just below the skin and is barely noticeable. The port can be palpated easily.
The port catheter tip usually lies in a large caliber vein, generally the superior vena cava, in the proximity of the right atrium of the heart. The catheter is generally advanced through the subclavian or jugular veins. The port chamber usually lies at the upper level of the right rib cage. The surgeon chooses the appropriate site.
Port catheter systems are either implanted on an in-patient or out-patient basis in generally less than one hour. A maximum of two incisions are made to place the port chamber below the skin and advance the catheter into a large caliber vein. Patients can choose between general or local anesthesia. This should be discussed with the attending surgeon.
There may be slight swelling and pain at the site of implantation during the first few postoperative days but this is normal. If this should persist and progress to skin redness, fever, or bleeding a doctor should be consulted immediately to prevent complications.
The surgical incisions are either sutured or closed by adhesive strips. These can be removed painlessly on the 8th postoperative day. If a dressing is no longer necessary the patient may shower and eventually bathe after complete wound healing. Patients should refrain from physical exertion for the first 14 days. The port may be used for therapy immediately.
All FDA drugs intended for intravenous application can be administered via the port/catheter system. These include infusions such as saline, glucose, electrolytes, anti-neoplastic agents, and analgesics such as morphine. As well as parenteral nutrition e.g. fats, amino acids, and blood products (thrombocyte concentrates).
The port catheter system can be used subsequent to puncture of the membrane with the special needle. Drugs are administered either:
The physician will decide which and when drugs are to be administered. It is important to flush the port/catheter system after usage otherwise clogging can occur.
Instructions and care guidelines must be followed. Patients should also carry their implant card in which all relevant details are documented.
IMPORTANT: The port chamber is not a reservoir for either blood or drugs ! It should only contain saline/heparin solution after flushing
Patients may either be in the sitting or supine position. Sterile technique is mandatory when puncture is performed to prevent infection thus ensuring long-term usage. Patients should turn their heads in the opposite direction of the puncture site and avoid speaking and breathing over the sterile field.
Sample procedure:
IMPORTANT: A needle is strictly intended for single use only and should not remain in place for more than 48h (danger of infection).
Patients must check for signs of inflammation at the puncture site daily and take notice of any axillary lymph node swelling. Any changes should be brought to the attention of a physician and nurse at once.
Flushing once every 3 months. This is usually done by the general practitioner when obtaining routine blood samples.Connected port needles are checked daily by medical and nursing staff. Regular flushing of the systems is required after administration of infusions.
This is particularly important after blood transfusions and infusion of differing medications which may possibly interact.
When applying a bolus, syringes of at least 10ml or larger are recommended. The same procedures are to be followed when extracting the needle. This ensures long term protection of the system.
| Problem | Possible cause | What can be done? |
| High resistance during injection, no aspiration of blood. | The tip of the catheter is resting on the vessel wall. |
|
| Port and catheter cannot be flushed under normal pressure. Blood cannot be drawn. | Occlusion (clogging) of the catheter. | In these cases a physician should be consulted immediately. The physician will then discuss what needs to be done. |
| Malaise, pain, and swelling of shoulder, neck and arm regions. | Venous thrombosis | |
| Pain or redness at the implantation site, fever with unusual discharge at the puncture site. | Infection of the port recess. | |
| Burning pain after infusion possibly accompanied by blister formation on the skin surface and swelling of the port recess. | Indicates system leakage. Medications are diffusing into surrounding tissues. |
| Problem | Possible cause | What can be done? |
| Rejection of the port by the body | Material incompatibility | In these cases a physician should be consulted immediately. The physician will then discuss what needs to be done. |
| Spontaneous dislocation of the port. | Improper fixation of the port during implantation. | |
| Dislocation of the port secondary to body movements. | Improper fixation of the port during implantation. | |
| Pinching of the catheter between collar bone and first rib. | Individual anatomical position, operative technique. |
The port is made of pure TITAN.
The material properties of our ports have been extensively tested.
Since it is metal, the corresponding properties cannot be averted.
Test results show a harmlessness for possible MRI examinations, which behave within the parameters, see below (see also instructions for use):
This portcathetersystem in combination with special portneedles is also indicated for power injection ( high pressure) of radiopaque material into the vascular blood system.
The system is appropriate to a maximum flow of 5ml/sec at maximum pressure of 300 PSI/21bar. Stability is tested and the suitable systems or needles are indicated separately.
